- Report
- September 2024
- 296 Pages
Global
From €3757EUR$4,197USD£3,200GBP
- Report
- January 2025
- 179 Pages
Global
From €2050EUR$2,290USD£1,746GBP
- Report
- September 2024
- 154 Pages
Global
From €2677EUR$2,990USD£2,280GBP
- Report
- May 2025
- 188 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 194 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 180 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 199 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 182 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 187 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 184 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 188 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 192 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 199 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 181 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 193 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 187 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- March 2025
- 147 Pages
Global
From €2685EUR$2,999USD£2,287GBP
- Report
- February 2025
- 140 Pages
Global
From €2685EUR$2,999USD£2,287GBP
- Report
- August 2024
- 141 Pages
Global
From €2685EUR$2,999USD£2,287GBP
- Report
- May 2025
- 143 Pages
Global
From €2685EUR$2,999USD£2,287GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more